中国当代医药2023，Vol.30Issue(36)：55-58,4.
血脂康胶囊联合阿托伐他汀治疗老年人非酒精性脂肪性肝病的临床优势评价
Evaluation of clinical advantages of Xuezhikang Capsules combined with Atorvastatin in the treatment of elderly patients with non-alcoholic fatty liver disease
摘要
Abstract
Objective To explore the effect of Xuezhikang Capsules combined with Atorvastatin in the treatment of elderly patients with non-alcoholic fatty liver disease.Methods A total of 200 elderly patients with non-alcoholic fatty liver disease admitted to Shangrao Municipal Hospital from January 2019 to January 2020 were selected as the research objects,and they were divided into observation group(100 cases)and control group(100 cases)according to random number table method.The control group was treated with Atorvastatin,and the observation group was treated with Xuezhikang Capsules combined with Atorvastatin.Blood lipid,liver function related indexes,total effective rate and total incidence of adverse reactions were compared between the two groups.Results After treatment,the levels of total cholesterol triglyceride,low-density lipopro-tein cholesterol in the observation group were lower than those in the control group,and the levels of high-density lipopro-tein cholesterol were higher than those in the control group,the differences were statistically significant(P＜0.05).After treatment,the levels of alanine aminotransferase(ALT),aspartate aminotransferase(AST)in observation group were lower than those in control group;and the levels of alkaline phosphatase(ALP)in observation group was higher than those in con-trol group,the differences were statistically significant.The total effective rate of treatment in observation group was higher than that in control group,and the total incidence of adverse reactions was lower than that in control group,the differences were statistically significant(P＜0.05).Conclusion Xuezhikang Capsules combined with Atorvastatin in the treatment of el-derly patients with NAFLD has significant overall clinical therapeutic effect,which can effectively improve the total effective rate and greatly reduce the probability of clinical unsafe events.The clinical safety is high,and it is suitable for clinical im-plementation and development.关键词
血脂康胶囊/阿托伐他汀/老年人非酒精性脂肪性肝病/临床优势Key words
Xuezhikang Capsules/Atorvastatin/Elderly patients with non-alcoholic fatty liver disease/Clinical advantages分类
医药卫生引用本文复制引用
曹亚利,易珍,杨宇..血脂康胶囊联合阿托伐他汀治疗老年人非酒精性脂肪性肝病的临床优势评价[J].中国当代医药,2023,30(36):55-58,4.基金项目
江西省上饶市科技计划一般项目(2021CZDX61). （2021CZDX61）
